Molecular Diversity

, Volume 14, Issue 2, pp 401–408

Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept

  • Michael Lisurek
  • Bernd Rupp
  • Jörg Wichard
  • Martin Neuenschwander
  • Jens Peter von Kries
  • Ronald Frank
  • Jörg Rademann
  • Ronald Kühne
Open Access
Full-Length Paper

DOI: 10.1007/s11030-009-9187-z

Cite this article as:
Lisurek, M., Rupp, B., Wichard, J. et al. Mol Divers (2010) 14: 401. doi:10.1007/s11030-009-9187-z

Abstract

Success in small molecule screening relies heavily on the preselection of compounds. Here, we present a strategy for the enrichment of chemical libraries with potentially bioactive compounds integrating the collected knowledge of medicinal chemistry. Employing a genetic algorithm, substructures typically occurring in bioactive compounds were identified using the World Drug Index. Availability of compounds containing the selected substructures was analysed in vendor libraries, and the substructure-specific sublibraries were assembled. Compounds containing reactive, undesired functional groups were omitted. Using a diversity filter for both physico-chemical properties and the substructure composition, the compounds of all the sublibraries were ranked. Accordingly, a screening collection of 16,671 compounds was selected. Diversity and chemical space coverage of the collection indicate that it is highly diverse and well-placed in the chemical space spanned by bioactive compounds. Furthermore, secondary assay-validated hits presented in this study show the practical relevance of our library design strategy.

Keywords

Bio informatics Drug design High throughput screening Library design Molecular diversity 
Download to read the full article text

Supplementary material

11030_2009_9187_MOESM1_ESM.doc (422 kb)
DOC 1 (DOC 422 KB)

Copyright information

© The Author(s) 2009

Authors and Affiliations

  • Michael Lisurek
    • 1
  • Bernd Rupp
    • 1
  • Jörg Wichard
    • 1
  • Martin Neuenschwander
    • 1
  • Jens Peter von Kries
    • 1
  • Ronald Frank
    • 2
  • Jörg Rademann
    • 1
    • 3
  • Ronald Kühne
    • 1
  1. 1.FMP Leibniz Institut für Molekulare PharmakologieBerlinGermany
  2. 2.Department of Chemical BiologyHZI Helmholz Centre for Infection ResearchBraunschweigGermany
  3. 3.Institut für Chemie und Biochemie, Freie Universität BerlinBerlinGermany

Personalised recommendations